Evidence mapPaperPMID 37886553Full record

ArticleResearch square2023

Heterogeneous genetic architectures and evolutionary genomics of prostate cancer in Sub-Saharan Africa.

Timothy Rebbeck, Rohini Janivara, Wenlong Chen, Ujani Hazra, Shakuntala Baichoo, Ilir Agalliu, Paidamoyo Kachambwa, Corinne Simonti, Lyda Brown, Saanika Tambe and 50 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

60 authors at 20 institutions in 10 countries.

Timothy RebbeckDana-Farber Cancer Insitute.ORCID 0000-0002-4799-1900
Rohini JanivaraGeorgia Institute of Technology.ORCID 0000-0002-0634-2357
Wenlong ChenUniversity of the Witwatersrand.
Ujani HazraGeorgia Institute of Technology.
Shakuntala BaichooUniversity of Mauritius.ORCID 0000-0002-9335-1939
Ilir AgalliuAlbert Einstein College of Medicine.ORCID 0000-0002-6248-5790
Paidamoyo KachambwaCentre for Proteomic and Genomic Research.
Corinne SimontiGeorgia Institute of Technology.
Lyda BrownGeorgia Institute of Technology.
Saanika TambeGeorgia Institute of Technology.
Michelle KimGeorgia Institute of Technology.
Maxine HarlemonGeorgia Institute of Technology.
Mohamed JallohHôpital Général Idrissa Pouye.ORCID 0000-0002-2190-328X
Dillon MuzondiwaCentre for Proteomic and Genomic Research.
Daphne NaidooCentre for Proteomic and Genomic Research.
Olabode AjayiCentre for Proteomic and Genomic Research.
Nana Snyper37 Military Hospital.
Lamine NiangHôpital Général Idrissa Pouye.
Halimatou DiopHôpital Aristide Le Dantec.
Medina NdoyeUniversite Cheikh Anta Diop de Dakar.
James MensahUniversity of Ghana Medical School.ORCID 0000-0003-4133-1722
Afua Darkwa-AbrahamsKorle Bu Teaching Hospital.ORCID 0000-0003-0649-3996
Richard BiritwumUniversity of Ghana Medical School.
Andrew AdjeiUniversity Of Ghana Medical School.
Akindele AdebiyiUniversity of Ibadan.ORCID 0000-0003-1869-7910
Olayiwola ShittuUniversity of Ibadan.
Olufemi OgunbiyiUniversity of Ibadan.
Sikiru AdebayoUniversity of Ibadan.
Maxwell NwegbuUniversity of Abuja Teaching Hospital and Cancer Science Center.
Hafees AjibolaUniversity of Abuja Teaching Hospital and Cancer Science Center.
Olabode OluwoleUniversity of Abuja and University of Abuja Teaching Hospital.
Mustapha JamdaUniversity of Abuja Teaching Hospital and Cancer Science Center.
Audrey PentzWits Health Consortium (PTY) Ltd.
Christopher HaimanUniversity of Southern California.ORCID 0000-0002-0097-9971
Petrus SpiesStellenbosch University.
Andre Van der MerweStellenbosch University.
Michael CookNational Cancer Institute.
Stephen J ChanockNational Cancer Institute.ORCID 0000-0002-2324-3393
Sonja I BerndtDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda.
Stephen WatyaMulago Hospital/Makere University.
Alex LubwamaMakerere University College of Health Sciences.
Mazvita MuchengetiNational Institute for Communicable Diseases a Division of the National Health Laboratory Service.
Sean DohertyUniversity of the Witwatersrand.
Natalie SmythUniversity of the Witwatersrand.
David LounsburyAlbert Einstein College of Medicine.
Brian FortierDana-Farber Cancer Institute.
Thomas RohanAlbert Einstein College of Medicine.
Judith JacobsonColumbia University.
Alfred NeugutColumbia University.
Ann HsingStanford University School of Medicine.
Alexander GusevDana-Farber Cancer Institute.ORCID 0000-0002-7980-4620
Oseremen Aisuodionoe-ShadrachUniversity of Abuja and University of Abuja Teaching Hospital.
Maureen JoffeWits Health Consortium (PTY) Ltd.
Ben Adusei37 Military Hospital.
Serigne GueyeUniversite Cheikh Anta Diop de Dakar.
Pedro FernandezStellenbosch University.
Jo McBrideCentre for Proteomic and Genomic Research.
Caroline AndrewsDana Farber Cancer Institute.
Lindsay PetersenCentre for Proteomic & Genomic Research.
Joseph LachanceGeorgia Institute of Technology.ORCID 0000-0002-4650-3741
Georgia Institute of Technology · USCenter for Genomic Science · ITUniversity of Abuja Teaching Hospital · NGDana-Farber Cancer Institute · USUniversity of Ibadan · NGAlbert Einstein College of Medicine · USStellenbosch University · ZAUniversity of Ghana · GHUniversity of the Witwatersrand · ZA37 Military Hospital · GHCheikh Anta Diop University · SNColumbia University · USUniversity Hospital of Larissa · GRHôpital Aristide Le Dantec · SNKorle Bu Teaching Hospital · GHMakerere University · UGMulago Hospital · UGNational Cancer Institute · UANational Health Laboratory Service · ZAStanford University · US

Funding

Multiethnic GWAS and TWAS to Inform Risk Prediction for Prostate CancerU01CA257328 · UNIVERSITY OF SOUTHERN CALIFORNIA · 2025 to 2025
$638k
NCI NIH HHS U01 CA184374NCI NIH HHS U01 CA257328
6 · The paper itself

Abstract

Men of African descent have the highest prostate cancer (CaP) incidence and mortality rates, yet the genetic basis of CaP in African men has been understudied. We used genomic data from 3,963 CaP cases and 3,509 controls recruited in Ghana, Nigeria, Senegal, South Africa, and Uganda, to infer ancestry-specific genetic architectures and fine-mapped disease associations. Fifteen independent associations at 8q24.21, 6q22.1, and 11q13.3 reached genome-wide significance, including four novel associations. Intriguingly, multiple lead SNPs are private alleles, a pattern arising from recent mutations and the out-of-Africa bottleneck. These African-specific alleles contribute to haplotypes with odds ratios above 2.4. We found that the genetic architecture of CaP differs across Africa, with effect size differences contributing more to this heterogeneity than allele frequency differences. Population genetic analyses reveal that African CaP associations are largely governed by neutral evolution. Collectively, our findings emphasize the utility of conducting genetic studies that use diverse populations.

Indexed as

Africagenetic heterogeneityhealth disparitiespopulation geneticsprostate cancer

Identifiers

PMID37886553
PMCPMC10602179
OpenAlexW4387571549

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.